NCT01025102

The Addition of Sufentanil Interscalene Block in Shoulder Surgery

Phase III Study of the Addition of Sufentanil to Interscalene Block in Shoulder Surgery

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 26 (actual)
• Sponsor: Bent Gymoese Jorgensen · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the effects and side effects of interscale block performed with Naropin 0.1% cum sufentanil or Naropin 0.1% in shoulder surgery.

Detailed description

The purpose of this study is to compare the duration of postoperative analgesia and supplemental opioid consumption and side effects of interscale block performed with Naropin 0.1% cum sufentanil or Naropin 0.1% in shoulder surgery

Conditions

• Postoperative Pain
• Shoulder Surgery

Interventions

Type	Name	Description
DRUG	Naropin 0.1% cum sufentanil	20ml of Naropin 0.1% cum sufentanil 1mikrog per ml

Timeline

• Start date: 2010-01-01
• Primary completion: 2012-11-01
• Completion: 2012-12-01
• First posted: 2009-12-03
• Last updated: 2013-04-02

Locations

1 site across 1 country: Denmark